SLC2A1 and psoriasis: Within the psoriatic group (G2), the Psoriasis Area and Severity Index (PASI) scores correlated positively with whole-blood GLUT1 mRNA fold changes and serum levels of IL-6, fetuin-A, and PTX3, and negatively with serum PEDF levels (Fig. 1).